Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boostrix during pregnan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acellular Pertussis
• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Poliomyelitis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)
• Infanrix Hexa (DTPa-HBV-IPV/Hib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2020-01-14